Oxford University to test Regeneron’s ‘antibody cocktail’ on hospitalised Covid-19 patients
Doctors in the UK will trial an experimental ‘antibody cocktail’ medicine on patients in hospital with Covid-19. The Oxford University team behind the pioneering RECOVERY trial in Britain, which discovered that the steroid dexamethasone can save patients’ lives, have announced the newest addition to their study. It is a therapy called REGN-COV2 made by the … Read more